Skip to content

Clinical trials

Phase 3 Lung Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 3 Country / region: Netherlands Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20121
20141
20151
20161
20171
20194
20201
20232
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting6
Active, not recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
United Therapeutics2
Aeris Therapeutics1
Eli Lilly and Company1
GlaxoSmithKline1
Grifols Therapeutics LLC1
Hoffmann-La Roche1
Mallinckrodt1
Novartis Pharmaceuticals1
Nuvalent Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases18
Respiratory Tract Diseases9
Carcinoma, Non-Small-Cell Lung5
Bronchial Diseases4
Lung Diseases, Obstructive4
Lung Neoplasms4
Pulmonary Disease, Chronic Obstructive4
Asthma3
Connective Tissue Diseases3
Pathologic Processes3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.